Does GLOFITAMAB Cause Febrile neutropenia? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Febrile neutropenia have been filed in association with GLOFITAMAB (Columvi). This represents 6.2% of all adverse event reports for GLOFITAMAB.
69
Reports of Febrile neutropenia with GLOFITAMAB
6.2%
of all GLOFITAMAB reports
2
Deaths
55
Hospitalizations
How Dangerous Is Febrile neutropenia From GLOFITAMAB?
Of the 69 reports, 2 (2.9%) resulted in death, 55 (79.7%) required hospitalization, and 7 (10.1%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for GLOFITAMAB.
What Other Side Effects Does GLOFITAMAB Cause?
Cytokine release syndrome (415)
Disease progression (183)
Off label use (129)
Death (125)
Neutropenia (109)
Pyrexia (78)
Covid-19 (62)
Drug ineffective (53)
Immune effector cell-associated neurotoxicity syndrome (45)
Infection (44)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which GLOFITAMAB Alternatives Have Lower Febrile neutropenia Risk?
GLOFITAMAB vs GLOFITAMAB-GXBM
GLOFITAMAB vs GLUCAGON
GLOFITAMAB vs GLUCAGON\GLUCAGON\WATER
GLOFITAMAB vs GLUCARPIDASE
GLOFITAMAB vs GLUCOPHAGE